![](/img/cover-not-exists.png)
Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy
Kizy, S., Altman, A., Hui, J.Y.C., Tuttle, T., Marmor, S., Lou, E., Greeno, E., Chang, K., Denbo, J.W., Jensen, E.Volume:
20
Journal:
HPB
DOI:
10.1016/j.hpb.2018.06.2052
Date:
September, 2018
File:
PDF, 46 KB
2018